July 17, 2023 /

Research Row Breakout Session: Exon Skipping Strategies – PPMD 2023 Annual Conference

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Research Row: Exon-Skipping Strategies

  • Sarepta Therapeutics ( SRP-5051)
  • Dyne Therapeutics (DYNE-251)
  • PepGen (EDO51)
  • BioMarin Pharmaceutical (BMN351)
  • Wave Life Sciences (WVE-N531)
  • Entrada Therapeutics (ENTR-601-44)
  • Avidity Biosciences (AOC 1044)
  • NS Pharma (NS-089)
2023 PPMD Annual Conference,
Conferences & Meetings

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo